Start Date
5-27-2021 9:00 AM
End Date
5-27-2021 5:00 PM
Description
ESRD patients are vulnerable to hypoglycemia due to impaired insulin clearance, glucose metabolism changes, and effects of dialysis. Hypoglycemic events lead to serious and life-threatening complications.
Aims for Improvement:
To decrease the rate of hypoglycemic events amongst ESRD patients receiving insulin for hyperkalemia treatment.
Keywords
Hypoglycemia, ESRD, Hyperkalemia protocol
Included in
Decreasing Post Insulin Hypoglycemia Incidence in End Stage Renal Disease (ESRD) patients
ESRD patients are vulnerable to hypoglycemia due to impaired insulin clearance, glucose metabolism changes, and effects of dialysis. Hypoglycemic events lead to serious and life-threatening complications.
Aims for Improvement:
To decrease the rate of hypoglycemic events amongst ESRD patients receiving insulin for hyperkalemia treatment.
Comments
Presented at the 2021 House Staff Quality Improvement and Patient Safety Conference